Journal article
Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy
Clinical obstetrics and gynecology, Vol.61(1), pp.146-156
03/2018
DOI: 10.1097/GRF.0000000000000345
PMID: 29351151
Abstract
Hepatitis C in pregnancy is on the rise, and new direct-acting antiviral agents are available that cure the disease. Published recommendations need to be reviewed and clinically evaluated for the care of pregnant women who are at risk for or have chronic hepatitis C. Available evidence and some of the medical and ethical reasons to consider universal screening and antepartum therapy for hepatitis C during pregnancy are presented. Universal screening and proactive treatment during pregnancy is on the horizon, and these measures should be quickly evaluated for safety and implemented if appropriate.
Details
- Title: Subtitle
- Hepatitis C in Pregnancy in the Era of Direct-acting Antiviral Treatment: Potential Benefits of Universal Screening and Antepartum Therapy
- Creators
- Helene B Bernstein - Departments of Obstetrics and Gynecology and Microbiology and Immunology, SUNY Upstate Medical University, Syracuse, New YorkJeffrey C Dunkelberg - Department of Internal Medicine, Division of Gastroenterology and HepatologyKimberly K Leslie - Department of Obstetrics and Gynecology, Division of Maternal-Fetal Medicine, Carver College of Medicine, University of Iowa, Iowa City, Iowa
- Resource Type
- Journal article
- Publication Details
- Clinical obstetrics and gynecology, Vol.61(1), pp.146-156
- Publisher
- United States
- DOI
- 10.1097/GRF.0000000000000345
- PMID
- 29351151
- ISSN
- 0009-9201
- eISSN
- 1532-5520
- Language
- English
- Date published
- 03/2018
- Academic Unit
- Obstetrics and Gynecology; Internal Medicine
- Record Identifier
- 9983931744302771
Metrics
19 Record Views